|
Volumn 2, Issue 3, 2004, Pages 181-184
|
Wyeth: The leader in women's health - Yesterday, today, and tomorrow
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BAZEDOXIFENE;
CONJUGATED ESTROGEN;
CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE;
DESVENLAFAXINE;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
NORADRENALIN UPTAKE INHIBITOR;
ORAL CONTRACEPTIVE AGENT;
SELECTIVE ESTROGEN RECEPTOR MODULATOR;
SEROTONIN UPTAKE INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
DYSMENORRHEA;
ENDOMETRIOSIS;
FEMALE;
HORMONAL THERAPY;
HOT FLUSH;
HUMAN;
LOW DRUG DOSE;
MENOPAUSAL SYNDROME;
MENTAL INSTABILITY;
ORAL CONTRACEPTION;
POSTTRAUMATIC OSTEOPOROSIS;
PRIORITY JOURNAL;
QUALITY OF LIFE;
REPRODUCTIVE HEALTH;
|
EID: 13244289967
PISSN: 15462501
EISSN: None
Source Type: Journal
DOI: 10.1016/j.sram.2004.07.012 Document Type: Review |
Times cited : (2)
|
References (0)
|